Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM: Satisfaction with AbobotulinumtoxinA in Glabellar Lines
NCT03687736Phase 4Completed
- Sponsor
- Galderma
- Start
- Oct 2018
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in glabellar lines, sponsored by Galderma. Started Oct 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT03687736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03687736.